# RDF export of group: Publication
<http://ctro/data#Publication_30310> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_30310> <http://www.w3.org/2000/01/rdf-schema#label> "Publication" .
<http://ctro/data#Publication_30310> <http://ctro/data#hasTitle> "The additive intraocular pressure - lowering effect of latanoprost 0 . 005 % daily once and pilocarpine 2 % t . i . d ." .
<http://ctro/data#Publication_30310> <http://ctro/data#hasAuthor> "Diestelhorst M" .
<http://ctro/data#Publication_30310> <http://ctro/data#hasPublicationYear> "2000" .
<http://ctro/data#Publication_30310> <http://ctro/data#hasJournal> "Graefes Arch Clin Exp Ophthalmol ." .
<http://ctro/data#Publication_30310> <http://ctro/data#hasPMID> "10901475" .
<http://ctro/data#Publication_30310> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_30317> .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_30317> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_30317> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial" .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasObjectiveDescription> "To compare the additional intraocular pressure - lowering effect of latanoprost 0 . 005 % administered once daily with that of pilocarpine 2 % administered three times daily in patients with" .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasNumberPatientsCT> "Two hundred and forty" .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasCTduration> "6 - month" .
<http://ctro/data#AllocationRatio_30321> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#IntentionToTreat> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "From the data we conclude that the additivity of latanoprost 0 . 005 % is at least as effective" .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasArm> <http://ctro/data#Arm_30364> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasPopulation> <http://ctro/data#Population_30343> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_30557> .
<http://ctro/data#EvidenceQuality_30329> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasObjectiveDescription> "primary open - angle glaucoma or ocular hypertension currently on monotherapy with timolol 0 . 5 % twice daily ." .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "as pilocarpine 2 % t . i . d ." .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "in reducing IOP when added to eyes currently on monotherapy" .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "with timolol 0 . 5 % b . i . d ." .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "Latanoprost was better tolerated than pilocarpine 2 % eye drops in this study ." .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasConclusionComment> "The increase in iris pigmentation requires further investigation ." .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#PerProtocol> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasArm> <http://ctro/data#Arm_30373> .
<http://ctro/data#ClinicalTrial_30317> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_30566> .
# RDF export of group: Population
<http://ctro/data#Population_30343> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_30343> <http://www.w3.org/2000/01/rdf-schema#label> "Population" .
<http://ctro/data#Population_30343> <http://ctro/data#hasPrecondition> "patients with primary open - angle glaucoma or ocular hypertension currently on monotherapy with timolol 0 . 5 % twice daily" .
<http://ctro/data#Ethnicity_30345> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_30343> <http://ctro/data#hasCountry> <http://ctro/data#Germany> .
<http://ctro/data#Gender_30350> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_30343> <http://ctro/data#hasPrecondition> "patients with POAG or OH whose IOP was not controlled with timolol 0 . 5 % b . i . d ." .
<http://ctro/data#Population_30343> <http://ctro/data#hasPrecondition> "Eyes had not been treated with pilocarpine and latanoprost for at least 2 years ." .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_26776> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_26776> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint-iop" .
<http://ctro/data#Endpoint_26776> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP> .
<http://ctro/data#Mean_26778> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_26776> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_26778> .
<http://ctro/data#Endpoint_26776> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg> .
<http://ctro/data#MeasurementDevice_26780> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_30353> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_30353> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint-iris" .
<http://ctro/data#AggregationMethod_30355> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_30356> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_30357> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#IrisPigmentation_30363> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IrisPigmentation> .
<http://ctro/data#Endpoint_30353> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IrisPigmentation_30363> .
<http://ctro/data#Endpoint_30358> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_30358> <http://www.w3.org/2000/01/rdf-schema#label> "Endpoint-oc" .
<http://ctro/data#EndPointDescription_30359> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_30358> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_30359> .
<http://ctro/data#AggregationMethod_30360> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_30361> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_30362> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_30364> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_30364> <http://www.w3.org/2000/01/rdf-schema#label> "Arm-lat" .
<http://ctro/data#Arm_30364> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_30476> .
<http://ctro/data#Arm_30364> <http://ctro/data#hasNumPatientsLeftArm> "Four" .
<http://ctro/data#Arm_30364> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_30422> .
<http://ctro/data#Arm_30364> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_30503> .
<http://ctro/data#Arm_30364> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_30382> .
<http://ctro/data#Arm_30373> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_30373> <http://www.w3.org/2000/01/rdf-schema#label> "Arm-pil" .
<http://ctro/data#Arm_30373> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_30388> .
<http://ctro/data#Arm_30373> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_30530> .
<http://ctro/data#Arm_30373> <http://ctro/data#hasNumPatientsLeftArm> "35" .
<http://ctro/data#Arm_30373> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_30449> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_30382> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_30382> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention-lat" .
<http://ctro/data#Intervention_30382> <http://ctro/data#hasMedication> <http://ctro/data#Medication_30400> .
<http://ctro/data#Intervention_30382> <http://ctro/data#hasFrequency> "daily once" .
<http://ctro/data#RelativeTime_30387> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_30388> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_30388> <http://www.w3.org/2000/01/rdf-schema#label> "Intervention-pil" .
<http://ctro/data#Intervention_30388> <http://ctro/data#hasMedication> <http://ctro/data#Medication_30407> .
<http://ctro/data#Intervention_30388> <http://ctro/data#hasFrequency> "t . i . d ." .
<http://ctro/data#RelativeTime_30393> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_30400> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_30400> <http://www.w3.org/2000/01/rdf-schema#label> "Medication-lat" .
<http://ctro/data#Latanoprost_30401> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost> .
<http://ctro/data#Medication_30400> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_30401> .
<http://ctro/data#Medication_30400> <http://ctro/data#hasDoseValue> "0 . 005" .
<http://ctro/data#Medication_30400> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage> .
<http://ctro/data#DeliveryMethod_30404> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_30407> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_30407> <http://www.w3.org/2000/01/rdf-schema#label> "Medication-pil" .
<http://ctro/data#Medication_30407> <http://ctro/data#hasDrug> <http://ctro/data#Pilocarpine> .
<http://ctro/data#Medication_30407> <http://ctro/data#hasDoseValue> "2" .
<http://ctro/data#Medication_30407> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage> .
<http://ctro/data#DeliveryMethod_30411> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_30422> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_30422> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome-iop-lat" .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_26776> .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasSdDevBL> "2 . 8" .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasResultMeasuredValue> "17 . 8" .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasSdDevResValue> "2 . 8" .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasChangeValue> "5 . 6" .
<http://ctro/data#Outcome_30422> <http://ctro/data#hasTimePoint> "6 months" .
<http://ctro/data#Outcome_30449> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_30449> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome-iop-pil" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_26776> .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasBaselineValue> "23 . 0" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasSdDevBL> "3 . 2" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasResultMeasuredValue> "18 . 5" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasSdDevResValue> "2 . 4" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasChangeValue> "4 . 8" .
<http://ctro/data#Outcome_30449> <http://ctro/data#hasTimePoint> "6 months" .
<http://ctro/data#Outcome_30476> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_30476> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome-iris-lat" .
<http://ctro/data#Outcome_30476> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_30353> .
<http://ctro/data#Outcome_30476> <http://ctro/data#hasNumberAffected> "Two" .
<http://ctro/data#Outcome_30503> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_30503> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome-oc-lat" .
<http://ctro/data#Outcome_30503> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_30358> .
<http://ctro/data#Outcome_30503> <http://ctro/data#hasNumberAffected> "Thirty - six" .
<http://ctro/data#Outcome_30530> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_30530> <http://www.w3.org/2000/01/rdf-schema#label> "Outcome-oc-pil" .
<http://ctro/data#Outcome_30530> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_30358> .
<http://ctro/data#Outcome_30530> <http://ctro/data#hasNumberAffected> "106" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_30557> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_30557> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups-ITT" .
<http://ctro/data#DiffBetweenGroups_30557> <http://ctro/data#hasDiffGroupAbsValue> "- 1 . 6" .
<http://ctro/data#DiffBetweenGroups_30557> <http://ctro/data#hasPvalueDiff> "P < 0 . 001" .
<http://ctro/data#DiffBetweenGroups_30557> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_30422> .
<http://ctro/data#DiffBetweenGroups_30557> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_30449> .
<http://ctro/data#DiffBetweenGroups_30566> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_30566> <http://www.w3.org/2000/01/rdf-schema#label> "DiffBetweenGroups-PP" .
<http://ctro/data#DiffBetweenGroups_30566> <http://ctro/data#hasDiffGroupAbsValue> "- 0 . 8" .
<http://ctro/data#DiffBetweenGroups_30566> <http://ctro/data#hasPvalueDiff> "P < 0 . 04" .
<http://ctro/data#DiffBetweenGroups_30566> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_30422> .
<http://ctro/data#DiffBetweenGroups_30566> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_30449> .
# RDF export of group: EvidenceQuality